HMGA2 and metastatic malignant neoplasm in the lymph nodes: In recent years, an increasing number of studies have demonstrated that the overexpression of HMGA2 is associated with lymph node metastasis, distant metastasis, and poor outcomes in OSCC patients (Gao et al. 2021; Liu et al. 2021; Yang, Liu et al. 2023).